Vimarsana
Biggest News Aggregation in the World

Raphael Townshend News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Raphael Townshend. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Raphael Townshend Today - Breaking & Trending Today

Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development - Vimarsana News

Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development

Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced that the Company has created the first large language model (LLM) leveraging chemical mapping data. In a preprint paper published on bioRxiv, Atomic AI describes ...

Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development - Vimarsana News

Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec 15, 2023--

Atomic AI Raises $35M in Series A Financing - Vimarsana News

Atomic AI Raises $35M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

With new funding, Atomic AI envisions RNA as the next frontier in drug discovery - Vimarsana News

With new funding, Atomic AI envisions RNA as the next frontier in drug discovery

The biotech industry is experiencing a rush of AI-powered tools for many aspects of the complex drug discovery process. But one that has flown under the radar,

With new funding, Atomic AI envisions RNA as the next frontier in drug discovery - Vimarsana News

With new funding, Atomic AI envisions RNA as the next frontier in drug discovery

With $35M in new funding, Atomic AI aims to do for RNA what AlphaFold did for proteins, and find entirely new treatments in the process.